Fundus Flavimaculatus: Is It the Same as Stargardt Disease?

Last updated: 10 November 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience

Fundus flavimaculatus is a term used in ophthalmology to describe a pattern of yellow-white flecks scattered across the retina. It is closely associated with Stargardt disease, an inherited retinal condition that commonly affects central vision. The two terms have historically been used to describe related clinical appearances, which can create confusion for patients reading eye reports.

In current clinical descriptions, fundus flavimaculatus is generally regarded as a phenotype within the Stargardt disease spectrum, particularly when flecks are more widely distributed across the retina. The exact diagnosis depends on clinical findings, imaging and, when appropriate, genetic testing. Read more about Stargardt disease and its retinal features.

At a Glance

  • Fundus flavimaculatus describes a retinal appearance with widespread yellow-white flecks.
  • It is closely linked to the Stargardt disease spectrum.
  • Both terms may be associated with inherited macular or retinal changes.
  • OCT, fundus autofluorescence and other retinal tests help characterise the condition.
  • Genetic testing may help clarify the diagnosis in selected cases.

Quick Navigation

What Does Fundus Flavimaculatus Mean?

The term fundus refers to the inside surface of the back of the eye, which includes the retina. Flavimaculatus refers to the yellowish spots or flecks that may be seen during retinal examination. These flecks are associated with changes involving the retinal pigment epithelium (RPE), a layer that supports the photoreceptors.

In this condition, flecks may extend beyond the central macula and be scattered more widely across the posterior retina. Their appearance and distribution can vary between individuals and may change over time.

Is It the Same as Stargardt Disease?

Fundus flavimaculatus is generally considered part of the Stargardt disease spectrum rather than an entirely unrelated condition. Stargardt disease is commonly associated with inherited changes involving the ABCA4 gene. The clinical pattern may include central macular changes and characteristic retinal flecks.

The term fundus flavimaculatus has often been used when flecks are more widely distributed and the condition may have a later onset or a different pattern of progression. However, appearance alone cannot establish the genetic cause or predict how an individual’s vision will change. A retina specialist may use the broader clinical diagnosis while considering the person’s examination and test results.

Symptoms and Clinical Features

Possible symptoms and findings include:

  • Gradual reduction in central vision.
  • Difficulty reading or recognising fine details.
  • Reduced colour discrimination.
  • Slow adjustment when moving between bright and dim environments.
  • Yellow-white retinal flecks visible during a dilated eye examination.
  • Macular changes that may be detected through retinal imaging.

Some people may have visible retinal flecks before they notice substantial visual difficulties. Others may experience symptoms earlier. The distribution of flecks does not reliably predict the degree of vision loss.

How Is It Diagnosed?

An ophthalmologist may review family history, visual acuity, colour vision and the appearance of the retina. Additional tests can include:

  • Optical coherence tomography (OCT): Shows cross-sectional retinal structure and may reveal changes in photoreceptor and RPE layers.
  • Fundus autofluorescence (FAF): Helps map patterns associated with lipofuscin accumulation and areas of retinal pigment epithelium change.
  • Fundus photography: Documents the distribution of retinal flecks and macular appearance.
  • Electroretinography (ERG): May be used to assess retinal function, particularly when disease extent is uncertain.
  • Genetic testing: May help identify relevant inherited variants and support family counselling.

Monitoring and Management

There is no single management plan suitable for every person with Stargardt disease or fundus flavimaculatus. Follow-up is based on symptoms, retinal imaging, visual function and the advice of the treating specialist. Low vision rehabilitation, magnifiers, screen readers and accessible digital settings can help with daily activities when central vision is affected.

Patients should discuss any proposed supplement, medication or experimental treatment with a qualified ophthalmologist. Avoid unproven products that promise to reverse inherited retinal disease.

Frequently Asked Questions

Is fundus flavimaculatus a separate disease?

It is generally described as a phenotype within the Stargardt disease spectrum, although the terminology may vary across clinical reports.

Does fundus flavimaculatus always cause severe vision loss?

No. The severity and progression vary. The distribution of retinal flecks alone cannot predict an individual’s visual outcome.

Is fundus flavimaculatus inherited?

It is commonly discussed in connection with inherited Stargardt disease, often involving ABCA4. The specific genetic explanation should be assessed individually.

Which test confirms Stargardt disease?

No single test is suitable for every patient. Diagnosis may combine clinical examination, OCT, fundus autofluorescence, ERG and genetic testing.

Medical References

For more information about Stargardt disease, symptoms and diagnosis, explore the other educational resources on this website.

Medical Disclaimer

This article is for educational purposes only and does not replace a retinal examination or genetic counselling. Terminology and diagnosis should be interpreted by a qualified eye specialist using the patient’s clinical findings and investigations.

Scroll to Top
Call Now Button